Munir, T., Yang, K., Xu, S., Williams, R., Shadman, M. (2025). Comparative efficacy of zanubrutinib (ZANU) versus fixed-duration acalabrutinib plus venetoclax (AV) for first-line treatment of chronic lymphocytic leukemia (CLL): A matching-adjusted indirect comparison (MAIC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e19032